Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,154 | 115 | 92.2% |
| Education | $264.97 | 3 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $361.99 | 5 | $0 (2024) |
| SOBI, INC | $241.02 | 9 | $0 (2024) |
| Astellas Pharma US Inc | $200.62 | 3 | $0 (2024) |
| PharmaEssentia USA Corporation | $188.93 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $172.10 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $167.66 | 8 | $0 (2024) |
| Stemline Therapeutics Inc. | $158.50 | 6 | $0 (2024) |
| Aveo Pharmaceuticals, Inc. | $153.53 | 6 | $0 (2024) |
| GENZYME CORPORATION | $148.63 | 2 | $0 (2023) |
| Eisai Inc. | $145.78 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,558 | 57 | PharmaEssentia USA Corporation ($151.47) |
| 2023 | $1,568 | 55 | Astellas Pharma US Inc ($184.98) |
| 2022 | $293.12 | 6 | Incyte Corporation ($205.00) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/29/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $32.65 | General |
| Category: Rare Disease | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.68 | General |
| 12/16/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.14 | General |
| 11/21/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $35.90 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/19/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Oncology | ||||||
| 10/28/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/22/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $23.26 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Immunology | ||||||
| 09/20/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Oncology | ||||||
| 09/13/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: Oncology | ||||||
| 09/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.76 | General |
| 09/05/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: HEMATOLOGY | ||||||
| 08/27/2024 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: BioOncology | ||||||
| 08/20/2024 | CSL Behring | Afstyla (Biological), Idelvion | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Hematology | ||||||
| 08/13/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $21.32 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 290 | 381 | $104,503 | $27,340 |
| 2021 | 5 | 327 | 446 | $123,791 | $37,534 |
| 2020 | 1 | 57 | 66 | $17,556 | $4,931 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 86 | 155 | $44,366 | $11,915 | 26.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 98 | 100 | $20,033 | $5,456 | 27.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 42 | 42 | $23,190 | $5,411 | 23.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 64 | 84 | $16,914 | $4,559 | 27.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 138 | 235 | $62,510 | $19,219 | 30.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 53 | 53 | $27,401 | $7,981 | 29.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 50 | 50 | $13,750 | $4,184 | 30.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 45 | 66 | $12,276 | $3,792 | 30.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 41 | 42 | $7,854 | $2,358 | 30.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 57 | 66 | $17,556 | $4,931 | 28.1% |
About Dr. Shanley Banaag, D.O
Dr. Shanley Banaag, D.O is a Hematology & Oncology healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2014. The National Provider Identifier (NPI) number assigned to this provider is 1427474840.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shanley Banaag, D.O has received a total of $3,419 in payments from pharmaceutical and medical device companies, with $1,558 received in 2024. These payments were reported across 118 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($3,154).
As a Medicare-enrolled provider, Banaag has provided services to 674 Medicare beneficiaries, totaling 893 services with total Medicare billing of $69,805. Data is available for 3 years (2020–2022), covering 10 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Norfolk, VA
- Active Since 03/10/2014
- Last Updated 07/15/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1427474840
Products in Payments
- BESREMI (Drug) $188.93
- Orserdu (Drug) $158.50
- DOPTELET (Drug) $154.28
- FOTIVDA (Drug) $153.53
- JAKAFI (Drug) $146.33
- Lenvima (Drug) $145.78
- MONJUVI (Drug) $135.67
- LIBTAYO (Biological) $121.53
- CABLIVI (Biological) $120.20
- ULTOMIRIS (Biological) $97.38
- Doptelet (Drug) $86.74
- Nubeqa (Drug) $82.47
- ADCETRIS (Biological) $81.07
- Stivarga (Drug) $74.89
- ZEJULA (Drug) $61.10
- Epkinly (Drug) $60.08
- BRUKINSA (Drug) $53.72
- QINLOCK (Drug) $53.27
- PLUVICTO (Drug) $49.03
- KEYTRUDA (Biological) $47.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Norfolk
Rabih Fahed, M.d, M.D
Hematology & Oncology — Payments: $337,010
Gary Simmons, Do, DO
Hematology & Oncology — Payments: $66,315
Michael Danso, M.d, M.D
Hematology & Oncology — Payments: $54,407
Thomas Alberico, Md, MD
Hematology & Oncology — Payments: $572.79
Dr. Ranjit Goudar, M.d, M.D
Hematology & Oncology — Payments: $549.21
Boon Cheng Kok, Md, MD
Hematology & Oncology — Payments: $539.63